A higher rate of multiple conditions associated with poor health among young people with high mean daily smartphone usage.
Roger Perlmutter lights up the biological dark, building a new pharma force in Eikon and its superpowered microscopes
HAYWARD, Calif. — After two decades at the highest R&D ranks of pharma, Roger Perlmutter has a blunt explanation for why drug development so often